Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/04/2789911/0/en/Absci-Announces-Collaboration-with-AstraZeneca-to-Advance-AI-Driven-Oncology-Candidate.html

VANCOUVER, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq:ABSI), a leader in generative AI antibody discovery, today announced a collaboration with AstraZeneca, a global biopharmaceutical company, to deliver an AI-designed antibody against an oncology target. This collaboration combines Absci’s Integrated Drug Creation™ platform with AstraZeneca’s expertise in oncology with the goal of accelerating the discovery of a potential new cancer treatment candidate.

Read more at globenewswire.com

Related news for (ABSI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.